High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells

Journal of Biological Chemistry

Volumn 287, Issue 40, 2012, Pages 33401-33411

  Jarmalavicius, Saulius ^a,b   Welte, Yvonne ^a   Walden, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNE RESPONSE; ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGENICITY; CELL CYCLE CONTROL; CELL SURFACES; CELLULAR PROCESS; CONTROL OF GENE EXPRESSION; DE NOVO SEQUENCING; DNA REPLICATIONS; GAIN INSIGHT; HUMAN LEUKOCYTE ANTIGEN; IMMUNOGENICITY; INTERVENTION STRATEGY; LIMITED PROTEOLYSIS; MELANOMA CELLS; MELANOMA TUMORS; PEPTIDE SEQUENCES; PREDICTION ALGORITHMS; PROTEIN METABOLISM; SYNTHETIC PEPTIDE; T CELLS; T-CELL EPITOPES; T-CELL RESPONSE; TUMOR CELLS; TUMOR SUPPRESSORS; TUMORIGENESIS; TWO-DIMENSIONAL HPLC;

ALGORITHMS; ANTIBODIES; CELL CULTURE; CELL MEMBRANES; DERMATOLOGY; GENE EXPRESSION; MASS SPECTROMETRY; ONCOLOGY; PEPTIDES; PLANTS (BOTANY); POLYPEPTIDES; SUPPORT VECTOR MACHINES; TUMORS;

ANTIGENS;

EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MESSENGER RNA;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CANCER INHIBITION; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOGENICITY; MASS SPECTROMETRY; MELANOMA CELL; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN METABOLISM;

ALGORITHMS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITOPES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LIGANDS; MASS SPECTROMETRY; MELANOMA; PEPTIDES; T-LYMPHOCYTES;

EID: 84866914575     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.358903     Document Type: Article

References (30)

1. Milner, E., Barnea, E., Beer, I., and Admon, A. (2006) The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol. Cell Proteomics 5, 357-365 (Pubitemid 43329313)
2. Demine, R., Sherev, T., and Walden, P. (2003) Biochemical determination of natural tumor-associated T-cell epitopes. Mol. Biotechnol. 25, 71-78
3. Demine, R., and Walden, P. (2005) Testing the role of gp96 as peptide chaperone in antigen processing. J. Biol. Chem. 280, 17573-17578 (Pubitemid 41388990)
4. Demine, R., and Walden, P. (2004) Sequit: Software for de novo peptide sequencing by matrix-assisted laser desorption/ionization post-source decay mass spectrometry. Rapid Commun. Mass Spectrom. 18, 907-913 (Pubitemid 38520257)
5. Mishra, G. R., Suresh, M., Kumaran, K., Kannabiran, N., Suresh, S., Bala, P., Shivakumar, K., Anuradha, N., Reddy, R., Raghavan, T. M., Menon, S., Hanumanthu, G., Gupta, M., Upendran, S., Gupta, S., Mahesh, M., Jacob, B., Mathew, P., Chatterjee, P., Arun, K. S., Sharma, S., Chandrika, K. N., Deshpande, N., Palvankar, K., Raghavnath, R., Krishnakanth, R., Karathia, H., Rekha, B., Nayak, R., Vishnupriya, G., Kumar, H. G., Nagini, M., Kumar, G. S., Jose, R., Deepthi, P., Mohan, S. S., Gandhi, T. K., Harsha, H. C., Deshpande, K. S., Sarker, M., Prasad, T. S., and Pandey, A. (2006) Human protein reference database-2006 update. Nucleic Acids Res. 34, D411-414
6. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A., and Stevanović, S. (1999) SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219 (Pubitemid 30099526)
7. Cambridge, S. B., Gnad, F., Nguyen, C., Bermejo, J. L., Krüger, M., and Mann, M. (2011) Systems-wide proteomic analysis in mammalian cells reveals conserved, functional protein turnover. J. Proteome Res. 10, 5275-5284
8. Bredenbeck, A., Losch, F. O., Sharav, T., Eichler-Mertens, M., Filter, M., Givehchi, A., Sterry, W., Wrede, P., and Walden, P. (2005) Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy. J. Immunol. 174, 6716-6724 (Pubitemid 40705633)
9. Reynolds, S. R., Celis, E., Sette, A., Oratz, R., Shapiro, R. L., Johnston, D., Fotino, M., and Bystryn, J. C. (2000) Identification of HLA-A*03, A*11, and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis. J. Immunol. Methods 244, 59-67
10. Chaux, P., Luiten, R., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V., Schultz, E., Cornelis, G. R., Boon, T., and van der Bruggen, P. (1999) Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J. Immunol. 163, 2928-2936 (Pubitemid 29399225)
11. Arnett, K. L., Huang, W., Valiante, N. M., Barber, L. D., and Parham, P. (1998) The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells. Immunogenetics 48, 56-61 (Pubitemid 28269079)
12. Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H. G. (1994) Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40, 238-241 (Pubitemid 24217868)
13. Kubo, R. T., Sette, A., Grey, H. M., Appella, E., Sakaguchi, K., Zhu, N. Z., Arnott, D., Sherman, N., Shabanowitz, J., and Michel, H. (1994) Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152, 3913-3924 (Pubitemid 24111063)
14. Jarmalavicius, S., Trefzer, U., and Walden, P. (2010) Differential arginine methylation of the G-protein pathway suppressor GPS-2 recognized by tumor-specific T cells in melanoma. Faseb. J. 24, 937-946
15. Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., and Van den Eynde, B. J. (2004) An antigenic peptide produced by peptide splicing in the proteasome. Science 304, 587-590 (Pubitemid 38541917)
16. Sidney, J., Peters, B., Frahm, N., Brander, C., and Sette, A. (2008) HLA class I supertypes: A revised and updated classification. BMC Immunol. 9, 1
17. Lennerz, V., Fatho, M., Gentilini, C., Frye, R. A., Lifke, A., Ferel, D., Wölfel, C., Huber, C., and Wölfel, T. (2005) The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl. Acad. Sci. U.S.A. 102, 16013-16018 (Pubitemid 41552859)
18. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. U.S.A. 92, 7976-7980
19. Hogan, K. T., Eisinger, D. P., Cupp, S. B., 3rd, Lekstrom, K. J., Deacon, D. D., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., Slingluff, C. L., Jr., and Ross, M. M. (1998) The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. Cancer Res. 58, 5144-5150 (Pubitemid 28521175)
20. + T cells. J. Exp. Med. 189, 757-766
21. Gaudin, C., Kremer, F., Angevin, E., Scott, V., and Triebel, F. (1999) A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma. J. Immunol. 162, 1730-1738 (Pubitemid 29307052)
22. Echchakir, H., Mami-Chouaib, F., Vergnon, I., Baurain, J. F., Karanikas, V., Chouaib, S., and Coulie, P. G. (2001) A point mutation in the α-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res. 61, 4078-4083 (Pubitemid 32720974)
23. Takenoyama, M., Baurain, J. F., Yasuda, M., So, T., Sugaya, M., Hanagiri, T., Sugio, K., Yasumoto, K., Boon, T., and Coulie, P. G. (2006) A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma. Int. J. Cancer 118, 1992-1997
24. Barrow, C., Browning, J., MacGregor, D., Davis, I. D., Sturrock, S., Jungbluth, A. A., and Cebon, J. (2006) Tumor antigen expression in melanoma varies according to antigen and stage. Clin. Cancer Res. 12, 764-771 (Pubitemid 43259856)
25. Harada, M., Li, Y. F., El-Gamil, M., Rosenberg, S. A., and Robbins, P. F. (2001) Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells. Cancer Res. 61, 1089-1094 (Pubitemid 32174429)
26. Peinado, H., Del Carmen Iglesias-de la Cruz, M., Olmeda, D., Csiszar, K., Fong, K. S., Vega, S., Nieto, M. A., Cano, A., and Portillo, F. (2005) A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 24, 3446-3458 (Pubitemid 41486782)
27. Liu, Y. F., Zhang, P. F., Li, M. Y., Li, Q. Q., and Chen, Z. C. (2011) Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Clin. Exp. Metastasis 28, 413-425
28. Mertsch, S., Schurgers, L. J., Weber, K., Paulus, W., and Senner, V. (2009) Matrix gla protein (MGP): An overexpressed and migration-promoting mesenchymal component in glioblastoma. BMC Cancer 9, 302
29. Matsumoto, T., Kawashima, Y., Nagashio, R., Kageyama, T., Kodera, Y., Jiang, S. X., Okayasu, I., Kameya, T., and Sato, Y. (2009) A new possible lung cancer marker: VGF detection from the conditioned medium of pulmonary large cell neuroendocrine carcinoma-derived cells using secretome analysis. Int. J. Biol. Markers 24, 282-285
30. Hickman, H. D., Luis, A. D., Buchli, R., Few, S. R., Sathiamurthy, M., VanGundy, R. S., Giberson, C. F., and Hildebrand, W. H. (2004) Toward a definition of self: Proteomic evaluation of the class I peptide repertoire. J. Immunol. 172, 2944-2952 (Pubitemid 38263681)